Consensus Stryker Corporation

Equities

SYK

US8636671013

Market Closed - Nyse 04:00:01 2024-04-17 pm EDT 5-day change 1st Jan Change
336 USD -0.48% Intraday chart for Stryker Corporation -3.25% +12.21%

Evolution of the average Target Price on Stryker Corporation

Price target over the last 5 years

History of analyst recommendation changes

98d76b.hbx3N-AeHZUpB_KlZ6tK8VpwCn0Ur79BKTgfsOKpf2A.sOgxY4J_dvhgX5_rLZ84pAwjZAwt28wMcFtx_q_fLDTo1A5zhlx_5RFrxg~7150e1f25f34cf6b84098a0e204e5fd2
Truist Securities Adjusts Stryker Price Target to $364 From $345 MT
BTIG Adjusts Stryker's Price Target to $366 From $353 MT
RBC Raises Price Target on Stryker to $386 From $360, Keeps Outperform Rating MT
TD Cowen Adjusts Price Target on Stryker to $400 From $365, Maintains Buy Rating MT
Citigroup Raises Price Target on Stryker to $406 From $362, Maintains Buy Rating MT
Fed officials fail to convince investors, who are focused on earnings Our Logo
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile... Our Logo
DA Davidson Raises Price Target on Stryker to $355 From $305, Cites Strong Sales Results, Keeps Buy/Add Rating MT
UBS Adjusts Stryker Price Target to $339 From $331, Maintains Neutral Rating MT
Deutsche Bank Raises Stryker Price Target to $345 From $300, Maintains Hold Rating MT
Citigroup Raises Price Target on Stryker to $362 From $340, Keeps Buy Rating MT
Evercore ISI Raises Price Target on Stryker to $340 From $320, Keeps Outperform Rating MT
Piper Sandler Adjusts Price Target on Stryker to $375 From $360, Keeps Overweight Rating MT
JPMorgan Raises Price Target on Stryker to $375 From $325, Keeps Overweight Rating MT
Canaccord Genuity Upgrades Stryker to Buy From Hold, Price Target is $360 MT
Roth MKM Raises Price Target on Stryker to $348 From $345, Keeps Buy Rating MT
TD Cowen Raises Price Target on Stryker to $365 From $322, Keeps Outperform Rating MT
Baird Raises Price Target on Stryker to $367 From $319, Keeps Outperform Rating MT
Jefferies Adjusts Price Target on Stryker to $390 From $345, Keeps Buy Rating MT
Wells Fargo Adjusts Price Target on Stryker to $364 From $336, Keeps Overweight Rating MT
Truist Securities Raises Price Target on Stryker to $345 From $330, Keeps Hold Rating MT
Morgan Stanley Lifts Price Target on Stryker to $345 From $320, Cites 'Strong 4Q Organic Growth Outperformance,' Keeps Equalweight Rating MT
RBC Lifts Price Target on Stryker to $360 From $345, Cites 'Solid' Q4 Beat, 'Strong' Initial 2024 Guidance, Keeps Outperform Rating MT
UBS Adjusts Stryker Price Target to $331 From $297, Maintains Neutral Rating MT
RBC Boosts Price Target on Stryker to $345 From $315, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
336 USD
Average target price
365.7 USD
Spread / Average Target
+8.83%
High Price Target
406 USD
Spread / Highest target
+20.82%
Low Price Target
242 USD
Spread / Lowest Target
-27.98%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Stryker Corporation

Truist Securities
BTIG
RBC Capital Markets
TD Cowen
Citigroup
DA Davidson
UBS
Deutsche Bank Securities
Evercore ISI
Piper Sandler
JPMorgan Chase
Canaccord Genuity
Wells Fargo Securities
Roth MKM
Baird
Jefferies & Co.
Morgan Stanley
BofA Securities
Barclays
Argus
Stifel Nicolaus
Loop Capital
KeyBanc Capital Markets
Goldman Sachs
Edward Jones
Cowen
Bernstein
SVB Leerink
Oppenheimer
Northland Securities
Credit Suisse
Raymond James
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
  1. Stock Market
  2. Equities
  3. SYK Stock
  4. Consensus Stryker Corporation